Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

http://www.wikidata.org/entity/Q33618516

about

Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.Processes to manage analyses and publications in a phase III multicenter randomized clinical trial A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression Host genetics predict clinical deterioration in HCV-related cirrhosis.Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning.Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial.Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV).Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study.Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?Natural history of HCV infection.Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers.Serum models accurately predict liver-related clinical outcomes in chronic hepatitis C.Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C.Prognostic value of liver fibrosis biomarkers: a meta-analysis.Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.The natural history of HCV-related cirrhosis and its temporal progression across the different clinical stages.Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.Liver failure after hepatocellular carcinoma surgery.Natural History of Hepatitis C.

P2860

Q26827517-E0B1A5B4-9042-4230-AADC-053D6802CF14 Q30250088-C621CD49-3C24-4F01-899B-EC89B631C1F3 Q33572715-BB13CB4C-D762-4BF1-B125-A2C02A5A22E6 Q33694159-A31CF06C-2426-4285-8B72-0D671CA5BFB8 Q33877980-2D79FCC2-FA84-432C-818C-1DF4C308AEBB Q34064042-E063B5E5-6242-44A2-991D-0C3F09EDBF5A Q34194979-C8DDBE37-5688-4761-9E38-C6E4D55B66C9 Q34207037-DBCEBE44-A868-485E-9FAD-99C9F9EF39AF Q34689664-C09FBEFB-7C47-4210-8B78-C5E971EEC78B Q34747195-01F42CF6-BA39-4308-B543-88C7AC192562 Q34851479-D69B66BC-C334-4F95-A40A-68D43FF34BB3 Q34873114-5F4DFDBF-3839-4C07-AA28-BE45934EEFE4 Q35131882-4445D567-FDB7-49B0-BCC6-4A33F08B156F Q35155028-6F44CAF0-CC42-475B-81CE-D03B21A75A61 Q35818743-1E80E3C9-A77D-4B11-85DD-D5FD9F1AC3D9 Q35948114-1CA1E6B7-0FE9-4962-89C2-55A00D8C6016 Q36104827-C352F2F4-B1D2-49A7-B518-1C7C649A3CE1 Q36174863-EB49948C-232F-4AF9-8B2F-C55F84AA0BB9 Q36374902-3F3E5F7B-3A09-4696-B3E1-D126D84E32C8 Q36759370-74430A8D-7624-46EB-BB76-8D7720DFE7F0 Q37883962-6443CFF4-C16B-401F-916C-B1BA34124B97 Q37897194-670CE705-DC6C-46F0-9A27-C20EBEEDB49C Q38552179-1F041929-639F-42D4-BA53-0A87C84CBFB6 Q38984408-0F966C53-4D47-4637-AEFB-695447572184 Q39077037-BDE35592-E43F-466F-8A7A-D13D8D10ABE9 Q39945747-B04F04FC-6DC9-43BC-A24A-1BBFBFBEEE62 Q40305694-F16A932F-9CF1-4B8E-A3C1-363B938B8B33 Q40621139-71CDD498-669C-4AF6-A94E-D9A9DE1CF866 Q40707324-AA64FA5D-DE3F-4A60-9C88-9B211E32A2CA Q40913201-BD1DFDAE-DEF3-4383-835B-75EED7EFFACF Q41556762-FDA3672E-2C1C-471B-813B-53553BC8F7E7 Q42219509-335F009A-89FC-4187-BA4C-F0BF7F5E1D74 Q42263146-E73A0872-00D5-42A5-A274-AE677E1522B1 Q50458059-90ADFC18-6D1E-4FB5-AB42-206D49D348C3 Q50934392-E720E60F-8070-42A2-89D9-7F7D001618E1

P2860

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

http://www.wikidata.org/entity/Q33618516

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Predicting clinical and histol ...... advanced chronic hepatitis C.

@ast

Predicting clinical and histol ...... advanced chronic hepatitis C.

@en

type

label

Predicting clinical and histol ...... advanced chronic hepatitis C.

@ast

Predicting clinical and histol ...... advanced chronic hepatitis C.

@en

prefLabel

Predicting clinical and histol ...... advanced chronic hepatitis C.

@ast

Predicting clinical and histol ...... advanced chronic hepatitis C.

@en

P1433

Q33618516-B68FE361-F247-4558-A0D7-32AFC3CA7DE2

P1476

Q33618516-F1AB66E6-D7ED-4C69-B120-0C0F23B5D33F

P2093

Q33618516-120948CA-2151-48B5-B711-5BB8E163596D

Q33618516-1551F4CD-6B9C-487B-92B1-33931DC3ABE0

Q33618516-20938486-ABCC-47EA-9F27-B9F26FAED6C3

Q33618516-26C3A51C-F597-4A34-AC9C-8623B94FE30B

Q33618516-3F93E604-26EE-4D72-92C5-4631A4901C64

Q33618516-5F69B560-96E1-478C-AFCC-3A41B33C86FF

Q33618516-8F623241-823F-457E-B4BF-3E084E707593

Q33618516-95150DC9-EF1C-4C30-AA7F-C5209B378C90

Q33618516-9F2FC419-A013-4A93-959F-4AF677EF99A8

Q33618516-B96C0123-11B6-4750-B8A9-16C4734426A5

P2860

Q33618516-022AC668-3BF2-4E87-B714-D4E2AD52F388

Q33618516-16E192C3-5268-4AFE-BECB-7699A05AAD84

Q33618516-1C9597D6-4FCD-429C-A73F-981D03946716

Q33618516-1DBB07CC-A25F-4F7B-9D58-4683012B39B7

Q33618516-21BDFA23-2AD8-411D-95FD-99FB364C0CA8

Q33618516-30CA289D-E8D3-40F8-A5CF-2BD96E7AF772

Q33618516-34907405-9F2F-4151-99B1-1AE9870D08C4

Q33618516-421A58C3-7662-4189-B498-FE5B9C162CA8

Q33618516-5221339B-2DD4-4084-8B41-4FC1B6F47DAD

Q33618516-553A0E20-409E-4AC6-86A8-893192DC7FFE

P304

Q33618516-BBCEF24E-733D-44FF-9FFD-95F62DDEB1AB

P31

Q33618516-A678187A-E017-4AAF-BEB4-3B5F27114095

P356

Q33618516-1A65D48E-7BC0-4E60-A830-DE9C1A3DC093

P407

Q33618516-FA11845D-01AF-4BB6-9D9B-2AC0A6A2C3F3

P433

Q33618516-1A669A8F-0373-4590-A238-9FBBBAF74751

P478

Q33618516-1B738628-150F-4D1B-80E3-7E38D706D609

P50

Q33618516-81A313E1-3B8B-4DAD-AFD0-80D1F816C186

Q33618516-9962E922-9C98-4BB8-82D4-B5BCCDE0B672

P577

Q33618516-C0DEA19D-FBC3-40B9-9D58-EC798477AACF

P5875

Q33618516-CDBB866A-85CF-4A95-B7BC-965849B80EC6

P698

Q33618516-939736E0-8C94-439D-B8D1-78008E31F1FD

P932

Q33618516-497006BF-88C2-4B73-A339-C76F9DCBAFCA

P356

J.GASTRO.2009.09.007

P1433

Gastroenterology

P1476

Predicting clinical and histol ...... n advanced chronic hepatitis C

@en

P2093

Anna S F Lok

http://www.w3.org/2001/XMLSchema#string

Anne M Stoddard

http://www.w3.org/2001/XMLSchema#string

Chihiro Morishima

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Wright

http://www.w3.org/2001/XMLSchema#string

Gregory T Everson

http://www.w3.org/2001/XMLSchema#string

HALT-C Trial Group

http://www.w3.org/2001/XMLSchema#string

Herbert L Bonkovsky

http://www.w3.org/2001/XMLSchema#string

James E Everhart

http://www.w3.org/2001/XMLSchema#string

Marc G Ghany

http://www.w3.org/2001/XMLSchema#string

Richard K Sterling

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Histological grading and staging of chronic hepatitis

Natural history of chronic hepatitis C

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Global challenges in liver disease.

P304

136-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.09.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Adrian M. Di Bisceglie

P577

2009-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26824117

http://www.w3.org/2001/XMLSchema#string

P698

19766643

http://www.w3.org/2001/XMLSchema#string

P932

2813393

http://www.w3.org/2001/XMLSchema#string